In her Diffusion article from the July/August 2017 issue of The Hematologist, Dr. Lori-Ann Linkins takes a look at the EINSTEIN CHOICE Study and compares reducing the intensity of anticoagulant therapy or switching to aspirin as options for patients who wish to continue being protected from the risk of VTE. She covers a New England Journal of Medicine article co-authored by Dr. Jeffrey Weitz. In this podcast, Dr. Weitz joins Dr. Linkins for a discussion of the study's design, rationale and important findings. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/7448.aspx.

Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/